The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.
 
Ronald C. Chen
Consulting or Advisory Role - Abbvie; Accuray; Accuray; Bayer; Blue Earth Diagnostics; Genentech; Medivation/Astellas; Myovant Sciences; Myovant Sciences; Pfizer
Research Funding - Accuray
 
Theodore Karrison
No Relationships to Disclose
 
Colleen Anne Lawton
Honoraria - Teladoc
 
William Adrian Hall
Research Funding - Elekta (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Hala Borno
Employment - Collective Health (I)
Leadership - Collective Health (I)
Stock and Other Ownership Interests - Collective Health (I)
Honoraria - Bristol-Myers Squibb; Dendreon
Consulting or Advisory Role - Bristol-Myers Squibb; Dendreon
 
Mihaela Rosu
No Relationships to Disclose
 
Ashesh B. Jani
Consulting or Advisory Role - Blue Earth Diagnostics
 
David M. Schuster
Employment - DigiRad (I)
Honoraria - Global Medical Solutions
Consulting or Advisory Role - AIM Specialty Health; Syncona
Research Funding - Advanced Accelerator Applications (Inst); Blue Earth Diagnostics (Inst); FUJIFILM (Inst); Nihon Medi-Physics (Inst); Telix Pharmaceuticals (Inst)
 
Michael J. Seider
No Relationships to Disclose
 
Jason A. Efstathiou
Consulting or Advisory Role - AstraZeneca; Blue Earth Diagnostics; Boston Scientific; Janssen; Roivant; Taris BioMedical
 
Edwin Melencio Posadas
Consulting or Advisory Role - CytoLumina; Genentech/Roche; Janssen Oncology; Janssen Oncology; Novartis
Speakers' Bureau - Bayer
Research Funding - PFizer
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
Travel, Accommodations, Expenses - TRACON Pharma
 
Paul L. Nguyen
Stock and Other Ownership Interests - Augmenix; Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Nanobiotix
Research Funding - Astellas Pharma; Bayer; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Honoraria - Genentech
Consulting or Advisory Role - Astellas Pharma; Blue Earth Diagnostics; Celgene; Genentech; Janssen Biotech; Myovant Sciences; Roivant; SerImmune
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)